Liu Yong-Ping, Wu Xue, Meng Jing-Hua, Yao Jun, Wang Bao-Jie
School of Forensic Medicine, China Medical University, Shenyang 110122, People's Republic of China.
Neuropsychiatr Dis Treat. 2020 Oct 12;16:2361-2370. doi: 10.2147/NDT.S268753. eCollection 2020.
Abnormal expression of the NR1 subunit of the N-methyl-d-aspartate (NMDA) receptor may potentially increase the susceptibility to neuropsychiatric diseases. The purpose of this study was to investigate the functional sequence of the 3'UTR of the human GRIN1 gene, which encodes the GluN1 receptor to determine the effect on the expression of GluN1 receptor.
We transferred seven recombinant pmirGLO recombinant vectors containing the 3'UTR truncated fragment of the GRIN1 gene into HEK-293, SK-N-SH, and U87 cell lines and compared the relative fluorescence intensity of adjacent length fragments. The TargetScan database was used to predict miRNAs. Then, miRNA mimics/inhibitors were co-transfected into the three cell lines with the 3'UTR of GRIN1 (pmirGLO - GRIN1), to investigate their influence on GRIN1 gene expression.
Compared with the pmirGLo-Basic vector, the relative fluorescence intensity of the complete GRIN1 gene 3'UTR recombinant sequence -27 bp - +1284 bp (the next base of the stop codon is +1) was significantly decreased in all three cell lines. The relative fluorescence intensities were significantly different between -27 bp - +294 bp and -27 bp - +497 bp regions, and between -27 bp - +708 bp and -27 bp - +907 bp regions. According to the prediction of the TargetScan database and analysis, miR-212-5p, miR-324-3p and miR-326 may bind to +295 bp - +497 bp, while miR-491-5p may bind to +798 bp - +907 bp. After co-transfection of miRNA mimic/inhibitor or mimic/inhibitor NC with a recombinant vector in the 3'UTR region of GRIN1 gene, we found that has-miR-491-5p inhibited GRIN1 expression significantly in all three cell lines, while has-miR-326 inhibitor upregulated GRIN1 expression in HEK-293 and U87 cells.
miR-491-5p may bind to the 3'UTR of the GRIN1 gene (+799 bp - +805 bp, the next base of the stop codon is +1) and down-regulate gene expression in HEK-293, SK-N-SH, and U87 cell lines, which implicates a potential role of miR-491-5p in central nervous system diseases.
N-甲基-D-天冬氨酸(NMDA)受体NR1亚基的异常表达可能会增加患神经精神疾病的易感性。本研究旨在探究人类GRIN1基因3'非翻译区(3'UTR)的功能序列,该基因编码GluN1受体,以确定其对GluN1受体表达的影响。
我们将七个含有GRIN1基因3'UTR截短片段的重组pmirGLO重组载体转入HEK-293、SK-N-SH和U87细胞系,并比较相邻长度片段的相对荧光强度。使用TargetScan数据库预测微小RNA(miRNA)。然后,将miRNA模拟物/抑制剂与GRIN1的3'UTR(pmirGLO - GRIN1)共转染到这三种细胞系中,以研究它们对GRIN1基因表达的影响。
与pmirGLo-Basic载体相比,完整的GRIN1基因3'UTR重组序列-27 bp - +1284 bp(终止密码子的下一个碱基为+1)在所有三种细胞系中的相对荧光强度均显著降低。-27 bp - +294 bp与-27 bp - +497 bp区域之间,以及-27 bp - +708 bp与-27 bp - +907 bp区域之间的相对荧光强度存在显著差异。根据TargetScan数据库的预测和分析,miR-212-5p、miR-324-3p和miR-326可能与+295 bp - +497 bp结合,而miR-491-5p可能与+798 bp - +907 bp结合。在将miRNA模拟物/抑制剂或模拟物/抑制剂阴性对照与GRIN1基因3'UTR区域的重组载体共转染后,我们发现has-miR-491-5p在所有三种细胞系中均显著抑制GRIN1表达,而has-miR-326抑制剂在HEK-293和U87细胞中上调GRIN1表达。
miR-491-5p可能与GRIN1基因的3'UTR(+799 bp - +805 bp,终止密码子的下一个碱基为+1)结合,并在HEK-293、SK-N-SH和U87细胞系中下调基因表达,这暗示了miR-491-5p在中枢神经系统疾病中的潜在作用。